Stegostoma fasciatum isolate 6-17 chromosome 34, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039260.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
ribosome biogenesis protein BMS1 homolog
family with sequence similarity 149 member B1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DnaJ (Hsp40) homolog, subfamily C, member 9
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear factor NF-kappa-B p100 subunit-like isoform X1
nuclear factor NF-kappa-B p100 subunit-like isoform X2
leucine-rich repeat-containing protein 20
transforming growth factor beta regulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transforming growth factor beta regulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transforming growth factor beta regulator 1 isoform X1
transforming growth factor beta regulator 1 isoform X2
transforming growth factor beta regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transforming growth factor beta regulator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transforming growth factor beta regulator 1 isoform X3
polyunsaturated fatty acid 5-lipoxygenase
tolloid-like protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tolloid-like protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphoinositide-3-kinase adaptor protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphoinositide-3-kinase adaptor protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphoinositide-3-kinase adaptor protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphoinositide 3-kinase adapter protein 1 isoform X3
phosphoinositide 3-kinase adapter protein 1 isoform X2
phosphoinositide 3-kinase adapter protein 1 isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X5
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X3
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X5
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01229
sorbin and SH3 domain-containing protein 1-like
PDZ and LIM domain 1 (elfin), transcript variant X1
PDZ and LIM domain 1 (elfin), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
paired box protein Pax-2-like, transcript variant X7
paired box protein Pax-2-like, transcript variant X1
paired box protein Pax-2-like, transcript variant X3
paired box protein Pax-2-like, transcript variant X4
paired box protein Pax-2-like, transcript variant X5
paired box protein Pax-2-like, transcript variant X9
paired box protein Pax-2-like, transcript variant X2
paired box protein Pax-2-like, transcript variant X8
paired box protein Pax-2-like, transcript variant X11
paired box protein Pax-2-like, transcript variant X6
paired box protein Pax-2-like, transcript variant X10
paired box protein Pax-2-like, transcript variant X12
paired box protein Pax-2-like, transcript variant X13
paired box protein Pax-2-like, transcript variant X14
paired box protein Pax-2-like, transcript variant X15
paired box protein Pax-2-like, transcript variant X16
paired box protein Pax-2-like isoform X7
paired box protein Pax-2-like isoform X14
paired box protein Pax-2-like isoform X6
paired box protein Pax-2-like isoform X5
paired box protein Pax-2-like isoform X12
paired box protein Pax-2-like isoform X10
paired box protein Pax-2-like isoform X2
paired box protein Pax-2-like isoform X11
paired box protein Pax-2-like isoform X9
paired box protein Pax-2-like isoform X3
paired box protein Pax-2-like isoform X1
paired box protein Pax-2-like isoform X16
paired box protein Pax-2-like isoform X15
paired box protein Pax-2-like isoform X13
paired box protein Pax-2a-like isoform X8
paired box protein Pax-2-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
growth hormone inducible transmembrane protein
growth hormone-inducible transmembrane protein
uncharacterized protein LOC555816 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC555816 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein si:ch1073-126c3.2 isoform X1
uncharacterized protein si:ch1073-126c3.2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
WASH complex subunit 2C, transcript variant X3
WASH complex subunit 2C, transcript variant X4
WASH complex subunit 2C, transcript variant X2
WASH complex subunit 2C, transcript variant X6
WASH complex subunit 2C, transcript variant X5
WASH complex subunit 2C, transcript variant X1
opsin 4a (melanopsin), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
opsin 4a (melanopsin), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
opsin 4a (melanopsin), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125467504, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC125467504, transcript variant X2
bone morphogenetic protein receptor, type IAa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
bone morphogenetic protein receptor, type IAa, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bone morphogenetic protein receptor, type IAa
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
shieldin complex subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
shieldin complex subunit 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
shieldin complex subunit 2, transcript variant X2
uncharacterized protein LOC561476 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
translocase of inner mitochondrial membrane 23 homolog a (yeast)
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mitochondrial import inner membrane translocase subunit Tim23
nuclear receptor coactivator 4, transcript variant X5
nuclear receptor coactivator 4, transcript variant X3
nuclear receptor coactivator 4, transcript variant X2
nuclear receptor coactivator 4, transcript variant X4
nuclear receptor coactivator 4, transcript variant X1
nuclear receptor coactivator 4 isoform X2
nuclear receptor coactivator 4 isoform X1
L-threonine ammonia-lyase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
L-threonine ammonia-lyase, transcript variant X2
L-threonine dehydratase catabolic TdcB isoform X2
transmembrane protein 254, transcript variant X1
transmembrane protein 254, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
CUE domain containing 2, transcript variant X1
CUE domain containing 2, transcript variant X2
F-box and leucine-rich repeat protein 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
hypoxia inducible factor 1 subunit alpha inhibitor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
hypoxia-inducible factor 1-alpha inhibitor
NADH:ubiquinone oxidoreductase subunit B8
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial
SEC31 homolog B, COPII coat complex component, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SEC31 homolog B, COPII coat complex component, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
SEC31 homolog B, COPII coat complex component, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein transport protein Sec31A isoform X1
protein transport protein Sec31A isoform X2
wingless-type MMTV integration site family, member 8b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
wingless-type MMTV integration site family, member 8b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Transmembrane protein 150A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Transmembrane protein 150A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Transmembrane protein 150A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 150A-like isoform X1
transmembrane protein 150A-like isoform X2
uncharacterized protein LOC796266 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC796266 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125467433, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125467433, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC125467433 isoform X1
uncharacterized protein LOC125467433 isoform X2
uncharacterized LOC125467433, transcript variant X3
uncharacterized protein LOC125467433 isoform X3
eukaryotic translation initiation factor 4E-binding protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatase domain containing paladin 1a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatase domain containing paladin 1a, transcript variant X3
phosphatase domain containing paladin 1a, transcript variant X2
phosphatase domain containing paladin 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphatase domain containing paladin 1a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatase domain containing paladin 1a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphatase domain containing paladin 1a, transcript variant X7
A disintegrin and metalloproteinase with thrombospondin motifs 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 3 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 3 isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 14 isoform X2
steroidogenic acute regulatory protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
microsomal triglyceride transfer protein large subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC125467541, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125467541, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein TBATA-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein TBATA-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein TBATA-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein TBATA-like, transcript variant X7
protein TBATA-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein TBATA-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein TBATA-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pyroglutamylated RF-amide peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
AP2-associated protein kinase 1-like, transcript variant X1
AP2-associated protein kinase 1-like, transcript variant X2
AP2-associated protein kinase 1-like, transcript variant X3
AP2-associated protein kinase 1-like, transcript variant X4
AP2-associated protein kinase 1-like isoform X2
AP2-associated protein kinase 1-like isoform X3
AP2-associated protein kinase 1-like isoform X4
AP2-associated protein kinase 1-like isoform X1
progestin and adipoQ receptor family member 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
progestin and adipoQ receptor family member 3-like isoform X2
progestin and adipoQ receptor family member 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
progestin and adipoQ receptor family member 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
progestin and adipoQ receptor family member 3-like isoform X3
progestin and adipoQ receptor family member 3-like isoform X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PR domain containing 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PR domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PR domain containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
growth differentiation factor 10a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
growth differentiation factor 10a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
growth/differentiation factor 10 isoform X1
growth/differentiation factor 10 isoform X3
growth differentiation factor 10a, transcript variant X2
growth/differentiation factor 10 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
protein tyrosine phosphatase non-receptor type 20, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X3
protein tyrosine phosphatase non-receptor type 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X4
protein tyrosine phosphatase non-receptor type 20, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X2
protein tyrosine phosphatase non-receptor type 20, transcript variant X1
tyrosine-protein phosphatase non-receptor type 13 isoform X6
FERM and PDZ domain-containing protein 2 isoform X3
tyrosine-protein phosphatase non-receptor type 13 isoform X7
FERM and PDZ domain-containing protein 2 isoform X4
FERM and PDZ domain-containing protein 2 isoform X5
FERM and PDZ domain-containing protein 2 isoform X2
tyrosine-protein phosphatase non-receptor type 13 isoform X1
protein tyrosine phosphatase non-receptor type 20, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X10
protein tyrosine phosphatase non-receptor type 20, transcript variant X8
FERM and PDZ domain-containing protein 2 isoform X9
protein tyrosine phosphatase non-receptor type 20, transcript variant X16
protein tyrosine phosphatase non-receptor type 20, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X15
protein tyrosine phosphatase non-receptor type 20, transcript variant X13
protein tyrosine phosphatase non-receptor type 20, transcript variant X9
FERM and PDZ domain-containing protein 2 isoform X11
FERM and PDZ domain-containing protein 2 isoform X8
protein tyrosine phosphatase non-receptor type 20, transcript variant X12
FERM and PDZ domain-containing protein 2 isoform X10
mitogen-activated protein kinase 8, transcript variant X1
mitogen-activated protein kinase 8, transcript variant X2
mitogen-activated protein kinase 8, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mitogen-activated protein kinase 8, transcript variant X4
mitogen-activated protein kinase 8, transcript variant X3
mitogen-activated protein kinase 8, transcript variant X10
mitogen-activated protein kinase 8, transcript variant X5
mitogen-activated protein kinase 8, transcript variant X7
mitogen-activated protein kinase 8, transcript variant X6
mitogen-activated protein kinase 8, transcript variant X8
mitogen-activated protein kinase 8, transcript variant X9
mitogen-activated protein kinase 8 isoform X1
mitogen-activated protein kinase 8 isoform X2
mitogen-activated protein kinase 8 isoform X3
rho GTPase-activating protein 22-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
rho GTPase-activating protein 22-like, transcript variant X2
rho GTPase-activating protein 22-like, transcript variant X1
rho GTPase-activating protein 22-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho GTPase-activating protein 22-like, transcript variant X4
rho GTPase-activating protein 22-like isoform X5
rho GTPase-activating protein 22-like isoform X2
rho GTPase-activating protein 22-like isoform X1
rho GTPase-activating protein 22-like isoform X3
rho GTPase-activating protein 22-like isoform X4
probable protein S-acyltransferase 23, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable protein S-acyltransferase 23, transcript variant X3
probable protein S-acyltransferase 23, transcript variant X1
probable protein S-acyltransferase 23 isoform X1
WDFY family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
WDFY family member 4, transcript variant X1
WD repeat- and FYVE domain-containing protein 4
leucine rich repeat containing 18a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine rich repeat containing 18a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 18 isoform X1
leucine-rich repeat-containing protein 18 isoform X2
V-set and transmembrane domain containing 4a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
V-set and transmembrane domain-containing protein 4a
transmembrane protein 273-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transmembrane protein 273-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC125467424 isoform X1
transmembrane protein 273-like isoform X2
cardiac-enriched FHL2-interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cardiac-enriched FHL2-interacting protein, transcript variant X4
cardiac-enriched FHL2-interacting protein, transcript variant X5
cardiac-enriched FHL2-interacting protein, transcript variant X2
cardiac-enriched FHL2-interacting protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cardiac-enriched FHL2-interacting protein
dorsal root ganglia homeobox, transcript variant X2
dorsal root ganglia homeobox, transcript variant X4
dorsal root ganglia homeobox, transcript variant X3
dorsal root ganglia homeobox, transcript variant X1
dorsal root ganglia homeobox protein isoform X1
dorsal root ganglia homeobox protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
excision repair cross-complementation group 6, transcript variant X4
excision repair cross-complementation group 6, transcript variant X1
excision repair cross-complementation group 6, transcript variant X3
excision repair cross-complementation group 6, transcript variant X2
excision repair cross-complementation group 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
excision repair cross-complementation group 6, transcript variant X6
DNA excision repair protein ERCC-6 isoform X4
DNA excision repair protein ERCC-6 isoform X1
DNA excision repair protein ERCC-6 isoform X2
DNA excision repair protein ERCC-6 isoform X3
DNA excision repair protein ERCC-6 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Ras association domain family member 4a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Ras association domain family member 4a, transcript variant X8
Ras association domain family member 4a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Ras association domain family member 4a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Ras association domain family member 4a, transcript variant X7
Ras association domain family member 4a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Ras association domain family member 4a, transcript variant X3
C-X-C motif chemokine 3-like, transcript variant X2
C-X-C motif chemokine 3-like, transcript variant X1
Ras association domain family member 4a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
alveolar macrophage chemotactic factor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ras association domain-containing protein 4a isoform X4
ras association domain-containing protein 4a isoform X1
ras association domain-containing protein 4a isoform X2
ras association domain-containing protein 4a isoform X3
uncharacterized LOC125467491, transcript variant X6
uncharacterized LOC125467491, transcript variant X1
uncharacterized LOC125467491, transcript variant X4
uncharacterized LOC125467491, transcript variant X5
uncharacterized LOC125467491, transcript variant X2
uncharacterized LOC125467491, transcript variant X3
uncharacterized protein LOC125467491 isoform X1
uncharacterized protein LOC125467491 isoform X2
uncharacterized LOC125467491, transcript variant X7
peroxisomal N(1)-acetyl-spermine/spermidine oxidase
mitochondrial ribosome-associated GTPase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
mitochondrial ribosome-associated GTPase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
mitochondrial ribosome-associated GTPase 1 isoform X2
mitochondrial ribosome-associated GTPase 1 isoform X1
enoyl CoA hydratase, short chain, 1, mitochondrial
fucose mutarotase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
fucose mutarotase, transcript variant X2
uncharacterized protein LOC368914 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein si:ch211-217g15.3
calcyon neuron-specific vesicular protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
tubulin, gamma complex associated protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 8-like isoform X1
disintegrin and metalloproteinase domain-containing protein 8-like isoform X2
sperm flagellar 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sperm flagellar 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sperm flagellar 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
catechol-O-methyltransferase domain containing 1
catechol O-methyltransferase domain-containing protein 1
uncharacterized LOC125467552, transcript variant X1
uncharacterized LOC125467552, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 106 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: neurofilament medium polypeptide-like
voltage-dependent anion channel 2, transcript variant X1
voltage-dependent anion channel 2, transcript variant X2
voltage-dependent anion channel 2, transcript variant X4
voltage-dependent anion channel 2, transcript variant X3
voltage-dependent anion-selective channel protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sphingomyelin synthase-related protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
dual specificity protein phosphatase 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
dual specificity phosphatase 29-like, transcript variant X2
dual specificity phosphatase 29-like, transcript variant X1
dual specificity phosphatase 29-like, transcript variant X3
dual specificity phosphatase 29-like isoform X1
dual specificity phosphatase 29-like isoform X2
K(lysine) acetyltransferase 6B, transcript variant X1
K(lysine) acetyltransferase 6B, transcript variant X2
histone acetyltransferase KAT6B isoform X1
histone acetyltransferase KAT6B isoform X2
adenosine kinase-like, transcript variant X4
adenosine kinase-like, transcript variant X5
adenosine kinase-like, transcript variant X1
adenosine kinase-like, transcript variant X2
adenosine kinase-like, transcript variant X3
AP-3 complex subunit mu-1, transcript variant X2
AP-3 complex subunit mu-1, transcript variant X1
AP-3 complex subunit mu-1, transcript variant X3
uncharacterized LOC125467561, transcript variant X2
uncharacterized LOC125467561, transcript variant X1
tissue-type plasminogen activator-like, transcript variant X2
tissue-type plasminogen activator-like, transcript variant X3
tissue-type plasminogen activator-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
component of inhibitor of nuclear factor kappa B kinase complex, transcript variant X3
component of inhibitor of nuclear factor kappa B kinase complex, transcript variant X1
component of inhibitor of nuclear factor kappa B kinase complex, transcript variant X2
inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1
inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X2
elongation of very long chain fatty acids protein 5-like
zinc finger protein 503, transcript variant X3
zinc finger protein 503, transcript variant X5
zinc finger protein 503, transcript variant X2
zinc finger protein 503, transcript variant X1
zinc finger protein 503, transcript variant X4
zinc finger protein 503, transcript variant X7
zinc finger protein 503, transcript variant X6
leucine rich melanocyte differentiation associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
leucine-rich melanocyte differentiation-associated protein isoform X1
leucine rich melanocyte differentiation associated, transcript variant X2
leucine-rich melanocyte differentiation-associated protein isoform X2
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X22
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X5
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X20
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X16
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X14
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X1
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-activated potassium channel subunit alpha-1a isoform X25
calcium-activated potassium channel subunit alpha-1a isoform X22
calcium-activated potassium channel subunit alpha-1a isoform X4
calcium-activated potassium channel subunit alpha-1a isoform X24
calcium-activated potassium channel subunit alpha-1a isoform X19
calcium-activated potassium channel subunit alpha-1a isoform X12
calcium-activated potassium channel subunit alpha-1a isoform X21
calcium-activated potassium channel subunit alpha-1a isoform X17
calcium-activated potassium channel subunit alpha-1a isoform X10
calcium-activated potassium channel subunit alpha-1a isoform X7
calcium-activated potassium channel subunit alpha-1a isoform X3
calcium-activated potassium channel subunit alpha-1a isoform X2
calcium-activated potassium channel subunit alpha-1a isoform X23
calcium-activated potassium channel subunit alpha-1a isoform X18
calcium-activated potassium channel subunit alpha-1a isoform X15
calcium-activated potassium channel subunit alpha-1a isoform X11
calcium-activated potassium channel subunit alpha-1a isoform X5
calcium-activated potassium channel subunit alpha-1a isoform X20
calcium-activated potassium channel subunit alpha-1a isoform X16
calcium-activated potassium channel subunit alpha-1a isoform X14
calcium-activated potassium channel subunit alpha-1a isoform X9
calcium-activated potassium channel subunit alpha-1a isoform X6
calcium-activated potassium channel subunit alpha-1a isoform X8
calcium-activated potassium channel subunit alpha-1a isoform X1
calcium-activated potassium channel subunit alpha-1a isoform X26
calcium-activated potassium channel subunit alpha-1a isoform X27
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X13
calcium-activated potassium channel subunit alpha-1a isoform X13
discs, large homolog 5a (Drosophila), transcript variant X17
discs, large homolog 5a (Drosophila), transcript variant X12
discs, large homolog 5a (Drosophila), transcript variant X11
discs, large homolog 5a (Drosophila), transcript variant X16
discs, large homolog 5a (Drosophila), transcript variant X15
discs, large homolog 5a (Drosophila), transcript variant X14
discs, large homolog 5a (Drosophila), transcript variant X5
discs, large homolog 5a (Drosophila), transcript variant X10
discs, large homolog 5a (Drosophila), transcript variant X9
discs, large homolog 5a (Drosophila), transcript variant X2
discs, large homolog 5a (Drosophila), transcript variant X6
discs, large homolog 5a (Drosophila), transcript variant X4
discs, large homolog 5a (Drosophila), transcript variant X8
discs, large homolog 5a (Drosophila), transcript variant X3
discs, large homolog 5a (Drosophila), transcript variant X7
discs, large homolog 5a (Drosophila), transcript variant X1
discs, large homolog 5a (Drosophila), transcript variant X13
elongation of very long chain fatty acids protein 6-like, transcript variant X1
elongation of very long chain fatty acids protein 6-like, transcript variant X2
elongation of very long chain fatty acids protein 6-like isoform X1
elongation of very long chain fatty acids protein 6-like isoform X2
elongation of very long chain fatty acids protein 6-like, transcript variant X3
elongation of very long chain fatty acids protein 6-like isoform X3
ferroptosis suppressor protein 1-like, transcript variant X3
ferroptosis suppressor protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ferroptosis suppressor protein 1-like, transcript variant X1
ferroptosis suppressor protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ferroptosis suppressor protein 1-like isoform X3
ferroptosis suppressor protein 1-like isoform X1
ferroptosis suppressor protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
cadherin-related family member 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cadherin-related family member 1a, transcript variant X2
cadherin-related family member 1 isoform X1
cadherin-related family member 1 isoform X2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, transcript variant X4
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, transcript variant X2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, transcript variant X3
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, transcript variant X1
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 isoform X1
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 isoform X2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1a, transcript variant X2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1a, transcript variant X1
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1a isoform X2
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1a isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable vesicular acetylcholine transporter-A
choline O-acetyltransferase a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
choline O-acetyltransferase a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
oxoglutarate dehydrogenase L, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
oxoglutarate dehydrogenase L, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
oxoglutarate dehydrogenase L, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
2-oxoglutarate dehydrogenase-like, mitochondrial isoform X1
2-oxoglutarate dehydrogenase-like, mitochondrial isoform X2
poly (ADP-ribose) glycohydrolase a, transcript variant X1
poly (ADP-ribose) glycohydrolase a, transcript variant X3
poly (ADP-ribose) glycohydrolase a, transcript variant X2
poly (ADP-ribose) glycohydrolase a, transcript variant X4
poly(ADP-ribose) glycohydrolase isoform X1
poly(ADP-ribose) glycohydrolase isoform X2
poly(ADP-ribose) glycohydrolase isoform X3
poly(ADP-ribose) glycohydrolase isoform X4
ribosomal protein S24, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ribosomal protein S24, transcript variant X1
zinc finger, MIZ-type containing 1a, transcript variant X10
zinc finger, MIZ-type containing 1a, transcript variant X2
zinc finger, MIZ-type containing 1a, transcript variant X4
zinc finger, MIZ-type containing 1a, transcript variant X1
zinc finger, MIZ-type containing 1a, transcript variant X7
zinc finger, MIZ-type containing 1a, transcript variant X3
zinc finger, MIZ-type containing 1a, transcript variant X11
zinc finger, MIZ-type containing 1a, transcript variant X12
zinc finger, MIZ-type containing 1a, transcript variant X8
zinc finger, MIZ-type containing 1a, transcript variant X9
zinc finger, MIZ-type containing 1a, transcript variant X23
zinc finger, MIZ-type containing 1a, transcript variant X14
zinc finger, MIZ-type containing 1a, transcript variant X22
zinc finger, MIZ-type containing 1a, transcript variant X5
zinc finger, MIZ-type containing 1a, transcript variant X6
putative uncharacterized protein DDB_G0271982
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
zinc finger MIZ domain-containing protein 1a isoform X1
zinc finger MIZ domain-containing protein 1a isoform X9
zinc finger MIZ domain-containing protein 1a isoform X5
zinc finger MIZ domain-containing protein 1a isoform X6
zinc finger MIZ domain-containing protein 1a isoform X7
zinc finger MIZ domain-containing protein 1a isoform X3
zinc finger MIZ domain-containing protein 1a isoform X13
zinc finger MIZ domain-containing protein 1a isoform X2
zinc finger MIZ domain-containing protein 1a isoform X4
zinc finger MIZ domain-containing protein 1a isoform X12
zinc finger, MIZ-type containing 1a, transcript variant X21
zinc finger MIZ domain-containing protein 1a isoform X11
zinc finger, MIZ-type containing 1a, transcript variant X16
zinc finger, MIZ-type containing 1a, transcript variant X15
zinc finger, MIZ-type containing 1a, transcript variant X20
zinc finger, MIZ-type containing 1a, transcript variant X17
zinc finger, MIZ-type containing 1a, transcript variant X19
zinc finger, MIZ-type containing 1a, transcript variant X13
zinc finger MIZ domain-containing protein 1a isoform X8
zinc finger, MIZ-type containing 1a, transcript variant X18
zinc finger MIZ domain-containing protein 1a isoform X10
peptidyl-prolyl cis-trans isomerase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger CCHC domain-containing protein 24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X2
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC1 isoform X1
DNA-directed RNA polymerase III subunit RPC1 isoform X2
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC1 isoform X3
2-hydroxyacylsphingosine 1-beta-galactosyltransferase-like
nucleolar protein dao-5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nucleolar protein dao-5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
nucleolar and coiled-body phosphoprotein 1-like isoform X2
nucleolar and coiled-body phosphoprotein 1-like isoform X1
nucleolar protein dao-5-like, transcript variant X3
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X1
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X2
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X3
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X4
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X2
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X3
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2a
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2
zinc finger, SWIM-type containing 8, transcript variant X1
zinc finger, SWIM-type containing 8, transcript variant X5
zinc finger, SWIM-type containing 8, transcript variant X2
zinc finger, SWIM-type containing 8, transcript variant X3
zinc finger, SWIM-type containing 8, transcript variant X4
zinc finger, SWIM-type containing 8, transcript variant X6
zinc finger SWIM domain-containing protein 8 isoform X1
zinc finger SWIM domain-containing protein 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil-helix-coiled-coil-helix domain containing 1, transcript variant X2
coiled-coil-helix-coiled-coil-helix domain containing 1, transcript variant X1
coiled-coil-helix-coiled-coil-helix domain-containing protein 1 isoform X2
coiled-coil-helix-coiled-coil-helix domain-containing protein 1 isoform X1
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alpha-(1,3)-fucosyltransferase 11 isoform X3
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X2
alpha-(1,3)-fucosyltransferase 11 isoform X2
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase 11 isoform X1
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
PH and SEC7 domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PH and SEC7 domain-containing protein 1-like, transcript variant X1
PH and SEC7 domain-containing protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PH and SEC7 domain-containing protein 1-like, transcript variant X5
PH and SEC7 domain-containing protein 1-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PH and SEC7 domain-containing protein 1-like, transcript variant X7
PH and SEC7 domain-containing protein 1-like, transcript variant X3
PH and SEC7 domain-containing protein 1-like, transcript variant X4
PH and SEC7 domain-containing protein 1-like isoform X1
PH and SEC7 domain-containing protein 1-like isoform X3
PH and SEC7 domain-containing protein 1-like isoform X2
PH and SEC7 domain-containing protein 1-like isoform X5
PH and SEC7 domain-containing protein 1-like isoform X4
PH and SEC7 domain-containing protein 1-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PH and SEC7 domain-containing protein 1-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
PH and SEC7 domain-containing protein 1-like isoform X6
PH and SEC7 domain-containing protein 1-like isoform X7
PH and SEC7 domain-containing protein 1-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
PH and SEC7 domain-containing protein 1-like, transcript variant X13
PH and SEC7 domain-containing protein 1-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PH and SEC7 domain-containing protein 1-like isoform X8
ras-GEF domain-containing family member 1A-like, transcript variant X3
ras-GEF domain-containing family member 1A-like, transcript variant X2
ras-GEF domain-containing family member 1A-like, transcript variant X6
ras-GEF domain-containing family member 1A-like, transcript variant X4
ras-GEF domain-containing family member 1A-like, transcript variant X5
ras-GEF domain-containing family member 1A-like isoform X2
ras-GEF domain-containing family member 1A-like, transcript variant X1
ras-GEF domain-containing family member 1A-like isoform X1
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X2
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 2
ret proto-oncogene receptor tyrosine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
proto-oncogene tyrosine-protein kinase receptor Ret
uncharacterized protein LOC565246 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: heparan-alpha-glucosaminide N-acetyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein si:ch211-248a14.8
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
nucleoside diphosphate-linked moiety X motif 13 isoform X2
nucleoside diphosphate-linked moiety X motif 13 isoform X1
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X1
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X3
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X2
prolyl 4-hydroxylase subunit alpha-1-like isoform X1
prolyl 4-hydroxylase subunit alpha-1-like isoform X2
phospholipase A2, group XIIB, transcript variant X1
phospholipase A2, group XIIB, transcript variant X2
phospholipase A2, group XIIB, transcript variant X3
group XIIB secretory phospholipase A2-like protein isoform X1
group XIIB secretory phospholipase A2-like protein isoform X2
oncoprotein induced transcript 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
oncoprotein induced transcript 3, transcript variant X2
oncoprotein-induced transcript 3 protein isoform X1
oncoprotein-induced transcript 3 protein isoform X2
mitochondrial calcium uniporter, transcript variant X1
mitochondrial calcium uniporter, transcript variant X2
calcium uniporter protein, mitochondrial isoform X1
calcium uniporter protein, mitochondrial isoform X2
mitochondrial calcium uptake 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mitochondrial calcium uptake 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mitochondrial calcium uptake 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
mitochondrial calcium uptake 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
calcium uptake protein 1, mitochondrial isoform X1
calcium uptake protein 1, mitochondrial isoform X2
calcium uptake protein 1, mitochondrial isoform X3
dnaJ homolog subfamily B member 12-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
dnaJ homolog subfamily B member 12-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
dnaJ homolog subfamily B member 12-like isoform X1
dnaJ homolog subfamily B member 12-like isoform X2
anaphase promoting complex subunit 16, transcript variant X2
anaphase promoting complex subunit 16, transcript variant X1
anaphase-promoting complex subunit 16 isoform X2
anaphase-promoting complex subunit 16 isoform X1
activating signal cointegrator 1 complex subunit 1, transcript variant X2
activating signal cointegrator 1 complex subunit 1, transcript variant X1
activating signal cointegrator 1 complex subunit 1
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, transcript variant X2
DNA damage-inducible transcript 4 protein
trypsin like peroxisomal matrix peptidase 1, transcript variant X2
trypsin like peroxisomal matrix peptidase 1, transcript variant X1
peroxisomal leader peptide-processing protease isoform X2
peroxisomal leader peptide-processing protease isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
heterogeneous nuclear ribonucleoprotein D-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein D-like, transcript variant X4
heterogeneous nuclear ribonucleoprotein D-like, transcript variant X5
heterogeneous nuclear ribonucleoprotein D-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein D-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein D-like isoform X3
heterogeneous nuclear ribonucleoprotein D0-like isoform X4
heterogeneous nuclear ribonucleoprotein D-like isoform X1
heterogeneous nuclear ribonucleoprotein D-like isoform X2
biogenesis of lysosomal organelles complex-1, subunit 2, transcript variant X2
biogenesis of lysosomal organelles complex-1, subunit 2, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 2 isoform X1
biogenesis of lysosome-related organelles complex 1 subunit 2 isoform X2
calcium-binding mitochondrial carrier protein SCaMC-2-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
V-type immunoglobulin domain-containing suppressor of T-cell activation
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00563
unc-5 netrin receptor B, transcript variant X2
unc-5 netrin receptor B, transcript variant X1
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha
pterin-4-alpha-carbinolamine dehydratase
paired-like homeodomain 3, transcript variant X3
paired-like homeodomain 3, transcript variant X2
paired-like homeodomain 3, transcript variant X1
paired-like homeodomain 3, transcript variant X4
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X1
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X3
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X6
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X4
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X7
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X8
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X9
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X10
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X1
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X3
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X6
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X2
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X4
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X7
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X8
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X5
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X12
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X9
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X10
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X11
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X11
core histone macro-H2A.2, transcript variant X2
core histone macro-H2A.2, transcript variant X3
core histone macro-H2A.2, transcript variant X1
collagen, type XIII, alpha 1, transcript variant X2
collagen, type XIII, alpha 1, transcript variant X4
collagen, type XIII, alpha 1, transcript variant X1
collagen, type XIII, alpha 1, transcript variant X7
collagen, type XIII, alpha 1, transcript variant X3
collagen, type XIII, alpha 1, transcript variant X6
collagen, type XIII, alpha 1, transcript variant X14
collagen, type XIII, alpha 1, transcript variant X15
collagen, type XIII, alpha 1, transcript variant X9
collagen, type XIII, alpha 1, transcript variant X8
collagen, type XIII, alpha 1, transcript variant X17
collagen, type XIII, alpha 1, transcript variant X11
collagen, type XIII, alpha 1, transcript variant X19
collagen, type XIII, alpha 1, transcript variant X16
collagen, type XIII, alpha 1, transcript variant X21
collagen, type XIII, alpha 1, transcript variant X20
collagen, type XIII, alpha 1, transcript variant X22
collagen, type XIII, alpha 1, transcript variant X23
collagen, type XIII, alpha 1, transcript variant X13
collagen, type XIII, alpha 1, transcript variant X10
collagen, type XIII, alpha 1, transcript variant X12
collagen, type XIII, alpha 1, transcript variant X18
collagen, type XIII, alpha 1, transcript variant X5
collagen alpha-1(XIII) chain isoform X13
collagen alpha-1(XIII) chain isoform X16
collagen alpha-1(XIII) chain isoform X10
collagen alpha-1(XIII) chain isoform X18
collagen alpha-1(XIII) chain isoform X15
collagen alpha-1(XIII) chain isoform X20
collagen alpha-1(XIII) chain isoform X19
collagen alpha-1(XIII) chain isoform X21
collagen alpha-1(XIII) chain isoform X22
collagen alpha-1(XIII) chain isoform X12
collagen alpha-1(XIII) chain isoform X11
collagen alpha-1(XIII) chain isoform X17
cGMP-dependent protein kinase 2, transcript variant X1
cGMP-dependent protein kinase 2, transcript variant X2
cGMP-dependent protein kinase 2 isoform X1
cGMP-dependent protein kinase 2 isoform X2
cGMP-dependent protein kinase 2, transcript variant X3
cGMP-dependent protein kinase 2 isoform X3
neurogenin-3-like, transcript variant X3
neurogenin-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurogenin-3-like, transcript variant X1
inactive ubiquitin carboxyl-terminal hydrolase 54-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
inactive ubiquitin carboxyl-terminal hydrolase 54-like, transcript variant X2
inactive ubiquitin carboxyl-terminal hydrolase 54-like, transcript variant X1
inactive ubiquitin carboxyl-terminal hydrolase 54-like isoform X3
inactive ubiquitin carboxyl-terminal hydrolase 54-like isoform X2
inactive ubiquitin carboxyl-terminal hydrolase 54-like isoform X1
uncharacterized LOC125467587, transcript variant X2
uncharacterized LOC125467587, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SEC24 homolog C, COPII coat complex component
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein transport protein Sec24C
serine-rich coiled-coil domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125467638, transcript variant X3
uncharacterized LOC125467638, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC125467638, transcript variant X2
uncharacterized protein LOC125467638 isoform X1
uncharacterized protein LOC125467638 isoform X2
glutamate receptor ionotropic, delta-1-like, transcript variant X2
glutamate receptor ionotropic, delta-1-like, transcript variant X1
glutamate receptor ionotropic, delta-1-like, transcript variant X3
glutamate receptor ionotropic, delta-1-like isoform X2
glutamate receptor ionotropic, delta-1-like isoform X1
glutamate receptor ionotropic, delta-1-like isoform X3
wings apart-like protein homolog, transcript variant X1
wings apart-like protein homolog, transcript variant X2
wings apart-like protein homolog, transcript variant X3
wings apart-like protein homolog, transcript variant X4
wings apart-like protein homolog isoform X1
wings apart-like protein homolog isoform X2
pro-neuregulin-3, membrane-bound isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments